Canada markets closed

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.07-0.19 (-3.04%)
At close: 04:00PM EST
6.11 +0.04 (+0.66%)
After hours: 06:02PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 128.72M
Enterprise Value 73.26M
Trailing P/E 27.86
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.33
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -31.22

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 321.79%
S&P500 52-Week Change 316.15%
52 Week High 312.47
52 Week Low 32.81
50-Day Moving Average 38.82
200-Day Moving Average 36.56

Share Statistics

Avg Vol (3 month) 31.52M
Avg Vol (10 day) 31.01M
Shares Outstanding 515.95M
Implied Shares Outstanding 6N/A
Float 814.69M
% Held by Insiders 125.81%
% Held by Institutions 123.61%
Shares Short (Dec. 30, 2021) 41.5M
Short Ratio (Dec. 30, 2021) 40.66
Short % of Float (Dec. 30, 2021) 4N/A
Short % of Shares Outstanding (Dec. 30, 2021) 49.39%
Shares Short (prior month Nov. 29, 2021) 41.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan. 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:300
Last Split Date 3Jan. 01, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul. 30, 2021
Most Recent Quarter (mrq)Oct. 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.60%
Return on Equity (ttm)-9.20%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-2.39M
Diluted EPS (ttm)-0.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)55.49M
Total Cash Per Share (mrq)3.49
Total Debt (mrq)26.96k
Total Debt/Equity (mrq)0.05
Current Ratio (mrq)129.63
Book Value Per Share (mrq)3.60

Cash Flow Statement

Operating Cash Flow (ttm)-9.47M
Levered Free Cash Flow (ttm)-6.28M